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Abstract The biopharmaceuticals market is cur-
rently outperforming the pharmaceuticals market and
is now valued at US$ 48 billion with an average
annual growth of 19%. Behind this success is a 100-
fold increase in productivities of eukaryotic expres-
sion systems. However, the productivity per cell has
remained unchanged for more than 10 years. The
engineering of the ER-resident protein folding
machinery is discussed together with an overview
of signal transduction pathways activated by heterol-
ogous protein overexpression to increase cell specific
productivities.
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Introduction
The demand for therapeutic proteins, i.e. monoclonal
antibodies, has been forecast to exceed production
capacities (Werner 2004). Moderate increases in
product titers and yields are expected to result in
significant savings in capital investment and con-
sumer costs (Werner 2004). Over the last decade
product titers have increased from *20 mg l–1 to
2 g l–1 (Werner 2004; Wurm 2004). These improve-
ments are largely attributable to increases in viable
cell densities. However, cell specific productivities
remained nearly constant during this time (Wurm
2004).
To improve cell specific productivities the bottle-
neck for heterologous protein secretion has to be
identified and resolved. In expression systems
exploiting multiple gene copies or strong promoters
the amount of secreted heterologous protein does not
increase proportionally with gene copy number
(Schro¨der 2007), messenger ribonucleic acid
(mRNA) (Schro¨der et al. 1999), or even the intracel-
lular amount of the heterologous protein (Schro¨der
and Friedl 1997). In these cells, the protein accumu-
lates in intracellular aggregates (Schro¨der and
Kaufman 2005), associates with the molecular chap-
erone heavy chain-binding protein (BiP)/glucose-
regulated protein of 78 kDa (GRP78)/karyogamy 2
protein (Kar2p) (Schro¨der and Kaufman 2005), and
induces dilation of the endoplasmic reticulum (ER)
(Dorner et al. 1989; Gennaro et al. 1991). Therefore,
exit of the correctly folded polypeptide chain from
the ER is the rate-limiting step for heterologous
protein secretion. I will discuss strategies to improve
cell specific productivities by engineering protein
folding in the ER and signal transduction pathways
activated by overexpression of heterologous proteins.
M. Schro¨der (&)
School of Biological and Biomedical Sciences, Durham
University, South Road, Durham DH1 3LE, UK
e-mail: martin.schroeder@durham.ac.uk
123
Biotechnol Lett (2008) 30:187–196
DOI 10.1007/s10529-007-9524-1
Protein folding in the ER
The ER-resident protein folding machinery has four
components: (1) Molecular chaperones assisting
other proteins to fold, (2) enzymes such as protein
disulfide isomerases (PDIs) and cis-trans peptidyl
prolyl isomerases (PPIs), (3) a degradation machin-
ery, and (4) signal transduction pathways that co-
ordinate protein folding demand with capacity. At
least three hierarchically organized chaperone sys-
tems operate in the ER, the heat shock protein of
70 kDa (HSP70) chaperones BiP and luminal HSP
seventy 1 protein (Lhs1p)/chaperone in the ER 1
protein/Ssi1p/GRP170/oxygen-regulated protein of
150 kDa (ORP150), the HSP90 chaperone GRP94/
adenotin/endoplasmin/tumor rejection antigen glyco-
protein of 96 kDa (gp96)/ER protein of 99 kDa/
HSP108/Ca2+-binding protein 4/protein kinase of
80 kDa, and the lectin chaperones calnexin/p88,
calreticulin/Ca2+-binding protein of 63 kDa (CAB-
63)/calregulin/Ca2+-regulated protein of 55 kDa
(CRP55)/high affinity Ca2+-binding protein (HA-
CBP), and calmegin/calnexin-t (Fig. 1). BiP works
on completely unfolded polypeptide chains and
translocates nascent polypeptide chains into the ER,
whereas GRP94 and the lectin chaperones work on
partially folded substrates.
BiP consists of an N-terminal ATPase domain and
a C-terminal substrate binding domain. BiP cycles
through rounds of adenosine triphosphate (ATP)
hydrolysis and adenosine diphosphate (ADP) ATP
exchange (Fig. 1), which makes BiP a chaperone
foldase (Winter and Jakob 2004). At least six DnaJ or
HSP40 co-chaperones stimulate the ATPase activity
of BiP and two growth after phage induction E
(GrpE) co-chaperones the ADP ATP exchange reac-
tion. In the ADP-bound form BiP has high affinity for
unfolded substrates. Substrates bound to BiP are
conformationally locked. ADP ATP exchange
decreases the affinity of BiP for unfolded substrates.
Substrate binding stimulates the ATPase activity of
BiP. Thus, protein folding requires ATP (Dorner and
Kaufman 1990). BiP and Lhs1p coordinate their
activities. Lhs1p is a nucleotide exchange factor for
BiP, and BiP stimulates the ATPase activity of Lhs1p
(Steel et al. 2004).
Cytosolic HSP90 chaperones are ATP-consuming
chaperone foldases (Fig. 1) regulated by several co-
chaperones that affect its ATPase activity, load
substrates onto HSP90 chaperones, assist in protein
folding, and target substrates to degradation pathways
(Strudwick and Schro¨der 2007). GRP94 co-chaper-
ones have not been identified, but other ER luminal
chaperones found in complexes with GRP94 may be
GRP94 co-chaperones. The KM value of GRP94 for
ATP is *100 lM and its intrinsic ATPase activity is
barely detectable. These data indicate that GRP94
may be a chaperone holdase, a chaperone that binds
to unfolded proteins, but does not cycle through ATP
hydrolysis cycles. A drop of adenine nucleoside
concentrations in stress situations may activate
GRP94 (Rosser et al. 2004).
The lectin chaperones share an N-terminal globu-
lar oligosaccharide-binding domain and a C-terminal
extended hairpin loop, the P domain, which provides
the chaperone function (Strudwick and Schro¨der
2007). Calnexin and calmegin are transmembrane
proteins. Calreticulin is a soluble protein. Most
proteins entering the ER are glycosylated by addition
of the oligosaccharide Glc3Man9GlcNAc2 (Glc = D-
glucose, Man = D-mannose, GlcNAc = N-Acetyl-2-
D-glucosamine). a-Glucosidases I and II rapidly
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remove the two terminal D-glucose residues. Calnexin
and calreticulin bind to this monoglucosylated oligo-
saccharide. Removal of the third D-glucose moiety by
a-glucosidase II releases the protein from calnexin/
calreticulin. Reglucosylation of unfolded proteins by
uridine diphosphate (UDP)-glucose:glycoprotein glu-
cosyl transferase (UGGT) triggers repeated
interactions with calnexin/calreticulin (Fig. 1). This
reglucosylation reaction consumes UDP-glucose.
Therefore, the calnexin chaperones are chaperone
foldases. The Saccharomyces cerevisiae genome
encodes a calnexin homolog, but no homolog for
UGGT, suggesting that the lectin chaperones may
also function as holdases. Demannosylation of N-
linked oligosaccharides trigger export of proteins to
the Golgi complex or their targeting for retrotrans-
location into the cytosol and proteasomal degradation
(Lederkremer and Glickman 2005; Ruddock and
Molinari 2006).
An expanding family of PDIs catalyzes the
formation and isomerization of disulfide bonds.
Disulfide bond formation requires the regeneration
of oxidized PDI catalyzed by the flavin adenine
dinucleotide (FAD)-dependent oxidases ER oxidation
1 protein (Ero1p)/ERO1-La, ERO1-Lb and essential
for respiration and viability 2 protein (Erv2p)
(Fig. 2). The final electron acceptor is molecular
oxygen. Oxidative protein folding accounts for
*25% of all reactive oxygen species (ROS) formed
in a cell (Tu and Weissman 2004) and is increased by
ER stress (Haynes et al. 2004). Disulfide bond
isomerization is independent of the Ero1p oxidases.
Reduced glutathione provides reducing equivalents to
remove incorrectly formed disulfide bonds. PDI has
chaperone holdase activity that is independent of its
protein disulfide isomerase activity (Wilkinson and
Gilbert 2004) and redox-regulated foldase activity
(Tsai et al. 2001).
Slowly folding proteins or folded incompetent
proteins have to be removed from chaperone cycles
to prevent them from poisoning the protein folding
machinery. This is achieved by targeting these
proteins for retrotranslocation into the cytosol and
degradation by the proteasome in a process called ER
associated protein degradation (ERAD) (Yoshida
2007) (Fig. 3). Proteins destined for ERAD are
recognized by BiP, PDI, and lectin sensors such as
ER-degradation enhancing a-mannosidase-like pro-
teins 1–3 (EDEM1–3)/homologous to mannosidase I
1 protein (Htm1p)/mannosidase-like 1 protein
(Mnl1p) and osteosarcoma-9 (OS-9)/yeast OS-9
homolog protein (Yos9p) (Gauss et al. 2006a). The
lectin sensor EDEM extracts unfolded proteins from
the calnexin cycle. ERAD substrates are then
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retrotranslocated into the cytosol via the secretory 61
(SEC61) channel or a channel formed by derlin
proteins, ubiquitinated by action of ubiquitin-conju-
gating enzymes (E2 enzymes) and ubiquitin ligases
(E3 enzymes), deglycosylated, and degraded by the
proteasome. Redundancy exists in the ubiquitination
machinery involved in ERAD. In yeast and mamma-
lian cells at least three distinct E2E3 complexes are
present in the ER membrane. The substrate specific-
ities of these complexes, as well as their substrate
selection rules are poorly understood. In yeast, the E3
ligase Hrd1p co-operates with Hrd3p and Yos9p to
select its substrates (Gauss et al. 2006b). Another
selection criterion is the time an unfolded protein
spends in foldase cycles. In the calnexin cycle,
demannosylation of N-linked oligosaccharides gen-
erates glycostructures recognized by lectins such as
EDEM1–3. Association of cytosolic HSP70s with the
nucleotide exchange factor B cell leukemia/lym-
phoma 2 (Bcl-2) associated athanogene protein 1
(BAG-1) (Alberti et al. 2003) and of cytosolic
HSP90s with the ubiquitin ligase carboxyl terminus
of heat shock cognate protein of 70 kDa (HSC70)
interacting protein (CHIP) (Ho¨hfeld et al. 2001)
targets proteins for proteasomal degradation. Associ-
ation of the DnaJ co-chaperone 58 kDa inhibitor of
double-stranded RNA activated protein kinase (PKR,
p58IPK) with HSP70 chaperones at the translocation
pore targets proteins, whose translocation into the ER
is stalled, for proteasomal degradation (Oyadomari
et al. 2006). If similar targeting mechanisms for
proteins folding slowly in the BiP foldase cycle exist,
is currently unknown.
Engineering of chaperone machineries
Engineering of chaperone holdases should be
straightforward. Holdases hold onto an unfolded
protein and act in an equimolar ratio to the unfolded
substrate, but are unable to support folding reactions.
Holdases may provide a buffer capacity to prevent
aggregation of unfolded proteins. Co-overexpression
of chaperone foldases may be beneficial to overex-
pression of holdases (Smith et al. 2004; Zhang et al.
2006b). Overexpression data for calnexin/calreticulin
and PDI are most easily explained by assuming that
this buffer capacity is increased. Calnexin or calret-
iculin overexpression generally improved
heterologous protein secretion (Chung et al. 2004;
Conesa et al. 2002; Kato et al. 2005). Overexpression
of one cycle constituent should not increase cycle
capacity, if this constituent is not limiting, and if
constituent levels are not co-regulated. The hypoth-
esis that calnexin or calreticulin are limiting for the
calnexin cycle seems unlikely, because of the high
abundance of these proteins. Alternatively, overex-
pression of calnexin or calreticulin may inactivate
lectins such as EDEM (Molinari et al. 2003; Oda
et al. 2003), which target unfolded proteins for
ERAD. Further, elevated calnexin or calreticulin
levels not supported by concomitant increases in
activities of other calnexin cycle components, may
convert these surplus amounts of calnexin and
calnexin into holdases or inactive chaperones.
PDI overexpression increased secretion of some,
but not all, heterologous proteins (Butz et al. 2003;
Damasceno et al. 2006; Inan et al. 2006; Kato et al.
2005; Mohan et al. 2007; Schro¨der 2007; Zhang et al.
2006b). PDI overexpression provides increased
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holdase activity in the ER. For example, overexpres-
sion of catalytically inactive PDI improved
heterologous protein secretion (Hayano et al. 1995).
PDI overexpression also improved secretion of het-
erologous proteins containing no disulfide bonds
(Powers and Robinson 2007; Smith et al. 2004; Vad
et al. 2005). Substrate selectivity of PDI may explain
why PDI overexpression failed to increase heterolo-
gous protein secretion in some studies (Butz et al.
2003; Damasceno et al. 2006; Mohan et al. 2007;
Schro¨der 2007). If this is the case, co-expression of
an alternative holdase, i.e. GRP94, may yield more
consistent results for different heterologous proteins.
Alternatively, increased rates of disulfide bond for-
mation or isomerization in PDI overexpressing cells
may explain increased heterologous protein secretion.
As an enzyme, PDI should function at substochio-
metric ratios to its substrates. In disulfide bond
formation, regeneration of oxidized PDI may become
rate-limiting in PDI overexpressing cells. PDI is an
abundant ER protein, making it unlikely that its
overexpression can significantly augment its catalytic
activities.
Engineering of foldases seems more difficult,
because of the complex regulation of these chaper-
ones (see above). BiP overexpression increased
heterologous protein secretion for about half of the
heterologous proteins studied (Chung et al. 2004;
Damasceno et al. 2006; Dorner et al. 1992; Hsu and
Betenbaugh 1997; Kim et al. 2003; Schro¨der 2007;
Smith and Robinson 2002; Zhang et al. 2006b), but
can also have negative effects (Dorner et al. 1992;
Schro¨der 2007). In cells overexpressing BiP one of its
co-chaperones, Lhs1p, or ER luminal ATP may
become limiting, converting BiP into a holdase or
inactive chaperone. This may target proteins towards
ERAD, stall translocation, convert Lhs1p into a
holdase or inhibit Lhs1p. Increased BiP activity may
stall the GRP94 and/or calnexin–calreticulin chaper-
one machineries, because of the hierarchy of ER
luminal chaperone systems. This again may target
heterologous proteins for ERAD. BiP overexpression
attenuates the unfolded protein response (UPR, see
below). Thus, BiP levels in WT and BiP overexpress-
ing cells expressing a heterologous protein may not
be dramatically different. Further, BiP overexpress-
ing cells may experience an imbalance in their
chaperone machineries, because the UPR co-ordi-
nates expression of several chaperones. Moreover, if
overexpression of BiP shifts the folding bottleneck to
the GRP94 and calnexin chaperone systems, upreg-
ulation of these chaperone systems by the UPR may
be blunted, because of suppression of UPR activation
by elevated BiP levels.
Unfolded protein response (UPR)
ER stress is the perturbation of the balance between the
folding capacity and the folding demand imposed on
the ER. To restore ER homeostasis, the UPR activates
expression of chaperone, PDI, PPI, and ERAD genes,
attenuates transcription of genes encoding secretory
proteins and general translation, induces phospholipid
synthesis, and induces an inflammatory response.
Apoptosis is induced if these actions fail to restore
ER homeostasis or in response to prolonged ER stress
(Schro¨der and Kaufman 2005).
The ER membrane of higher eukaryotes harbors at
least three classes of transmembrane proteins acti-
vated by ER stress, basic leucine zipper (bZIP)
transcription factors synthesized as type II transmem-
brane proteins, of which the best characterized are
activating transcription factor 6a (ATF6a) and
ATF6b/cyclic adenosine monophosphate response
element binding protein (CREB)-related protein
(CREB-RP)/G13, the protein kinase eukaryotic trans-
lation initiation factor 2a (eIF2a) kinase 3
(EIF2AK3)/pancreatic eIF2a kinase (PEK)/PKR-like
ER kinase (PERK), and the protein kinase-endoribo-
nucleases ER to nucleus signaling 1a (ERN1a)/
inositol-requiring 1a (IRE1a) and IRE1b (Fig. 4).
Several ATF6 paralogs, CREB3, CREB4, CREB-H,
box B binding factor 2 (BBF2), and old astrocyte
specifically induced substance (OASIS) have recently
been described. In unstressed cells, these stress
sensors are bound to BiP and kept in an inactive
state. Upon ER stress, BiP is released coinciding with
their activation. Whether BiP release is triggered by
sequestration by unfolded proteins, conformational
changes in the ER luminal domains, or reactivation of
the BiP ATPase cycle is currently being debated
(Kimata et al. 2004; Shen et al. 2005). ER stress also
alters interactions of pro- and antiapoptotic Bcl-2
proteins at the ER membrane. These proteins regulate
ER luminal Ca2+ homeostasis, ER morphology, ER
stress signaling, and apoptosis induced in response to
ER stress (Hetz 2007).
Biotechnol Lett (2008) 30:187–196 191
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BiP release from ATF6 induces translocation of
ATF6 to the Golgi complex where its bZIP tran-
scription factor domain is proteolytically released
from the Golgi membrane by site 1 and 2 proteases
(S1P and S2P) (Fig. 4). This cytosolic fragment
translocates to the nucleus and induces expression of
chaperone genes (Strudwick and Schro¨der 2007). The
functions of the ATF6 paralogs in the ER stress
response is less well understood. OASIS contributes
to activation of the BiP gene (Kondo et al. 2005), and
ATF6CREB-H heterodimers activate inflammatory
genes (Zhang et al. 2006a).
BiP release from PERK triggers oligomerization
and activation of the protein kinase domain of PERK.
PERK phosphorylates the bZIP transcription factor
nuclear factor erythroid 2 (NF-E2) related factor 2
(NRF2) and eIF2a (Strudwick and Schro¨der 2007)
(Fig. 4). NRF2 phosphorylation induces its translo-
cation to the nucleus, where a NRF2ATF4
heterodimer activates transcription of antioxidant
response genes (Harding et al. 2003) to counteract
ROS formation by repeated folding attempts of
nascent polypeptide chains in ER stressed cells.
eIF2a phosphorylation attenuates general translation
and decreases the influx of nascent unfolded poly-
peptide chains into the ER. It also clears short-lived
proteins from the cell, i.e. D-type cyclins, resulting in
cell cycle arrest in G1 phase, and of inhibitors of
nuclear factor jB (NF-jB) (IjB), activating the pro-
inflammatory transcription factor NF-jB. eIF2a
phosphorylation also induces preferential translation
of capped mRNAs containing several short upstream
open reading frames (uORFs) and cap-independent
translation of mRNA via internal ribosomal entry
sites (IRES). Currently, the only known mRNA
whose translation is stimulated by ER stress is the
mRNA encoding the bZIP transcription factor ATF4.
ATF4 induces expression of CCAAT enhancer bind-
ing protein (C/EBP) homologous protein (CHOP)/
CHOP-10/growth arrest and DNA damage-inducible
gene 153 (GADD153). CHOP represses transcription
of anti-apoptotic BCL-2 (McCullough et al. 2001)
and induces expression of pro-apoptotic tribbles-
related protein 3 (TRB3) (Ohoka et al. 2005). Trans-
lational attenuation by PERK is transient and
countered by several eIF2a phosphatases. The regu-
latory subunit of protein phosphatase 1 (PP1),
GADD34, is induced late in ER stress by ATF4,
and targets PP1 to eIF2a.
Upon BiP release, IRE1 autophosphorylates in trans
and activates its endoribonuclease domain (Strudwick
and Schro¨der 2007). Activated IRE1 cleaves exon-
intron junctions in the mRNAs encoding the bZIP
transcription factors homologous to ATF/CREB1
protein (Hac1p) in yeast, HACA in filamentous fungi,
and X box-binding protein 1 (XBP-1)/hepatocarcino-
genesis-related transcription factor (HTF)/tax-
responsive element binding protein 5 (TREB5) in
metazoans (Fig. 4). In yeast, the HAC1 exons are
ligated by transfer RNA ligase. Both transcription
factors activate expression of genes encoding ER-
resident molecular chaperones, protein foldases, and
genes encoding proteins involved in ERAD. Hac1p and
XBP-1 also stimulate phospholipid biosynthesis.
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Spliced Hac1p represses genes under control of the
transcriptional regulator unscheduled meiosis 6 pro-
tein (Ume6p), including the early meiotic genes and a
large array of genes involved in carbon and nitrogen
metabolism. This function of spliced Hac1p may
explain the slow growth phenotype of yeast cells
overexpressing Ire1p or spliced Hac1p (Mori et al.
2000). Attenuation of metabolism by Hac1p in yeast
may substitute for attenuation of general translation by
PERK. XBP-1 activation is delayed compared to ATF6
and PERK activation (Yoshida et al. 2003), allowing
for an early folding only phase in the UPR followed by
a folding and degradation phase. In mammals, phos-
phorylated IRE1 sequesters tumor necrosis factor
receptor associated factor 2 (TRAF2) from pro-caspase
12, resulting in clustering and activation of this caspase
and initiation of apoptosis (Strudwick and Schro¨der
2007) (Fig. 4). TRAF2 recruits apoptosis signal-reg-
ulating kinase 1 (ASK1) and IjB kinase to IRE1. ASK1
activates the mitogen-activated protein (MAP) kinases
p38 and ju-nana (jun) N-terminal kinases (JNKs). p38
and JNKs phosphorylate and potentiate pro-apoptotic
transcription factors, i.e. CHOP and c-Jun, and phos-
phorylate and inhibit anti-apoptotic Bcl-2 and Bcl-xL
to induce apoptosis (Szegezdi et al. 2006). Inhibition
of JNK phosphatases by ROS formed in oxidative
protein folding also contributes to JNK activation
(Kamata et al. 2005). Association of the pro-apoptotic
Bcl-2 family proteins Bax and Bak with the cytosolic
portion of IRE1 is required for efferent IRE1 signaling,
i.e. XBP-1 mRNA splicing and JNK1 activation (Hetz
et al. 2006).
Engineering of the UPR
Engineering of the UPR holds promise to increase
concentrations of several chaperones in a functionally
meaningful ratio, thus preventing inadvertent con-
version of chaperone foldases into holdases, or even
inactivating chaperones because of lack of concom-
itant increases in co-chaperones and co-factors. The
UPR is as much a survival response as it is a response
to boost protein secretion. Clearly, some aspects of
the physiological UPR are not desirable in an
expression system, for example inhibition of general
translation by PERK, stimulation of ERAD and
apoptosis. Overexpression of spliced Hac1p or its
filamentous fungi homolog HACA increased
heterologous protein secretion in Saccharomyces
cerevisiae and Aspergillus niger (Valkonen et al.
2003a, b). In Chinese hamster ovary (CHO)-K1 cells
XBP-1 overexpression improved secretion of several
heterologous proteins (Ku et al. 2007; Tigges and
Fussenegger 2006). In yeast and filamentous fungi,
secretion of several heterologous proteins was not
improved or even decreased by overexpression of
Hac1p (Gasser et al. 2006; Rakestraw and Wittrup
2005; Valkonen et al. 2003a). One drawback of some
of these studies is that wild-type (WT) cells with a
functional UPR are compared to WT cells over-
expressing spliced Hac1p, which may explain why in
some cases only marginal differences between the
two cell types have been observed. The more
consistent effect of spliced XBP-1 overexpression
on protein secretion (Ku et al. 2007; Tigges and
Fussenegger 2006) may be caused by a preferential
activation of UPR signaling pathways that stimulate
cellular functions beneficial for heterologous protein
secretion, i.e. increased chaperone gene expression.
This increased ER-resident chaperone machinery
attenuates all UPR signaling, and most importantly,
those UPR signaling pathways likely to decrease
protein production, for example general translation
inhibition by PERK, stimulation of ERAD and of
apoptosis (O¨zcan et al. 2004).
Conclusions
Engineering of chaperone systems by overexpressing
a single component of the ER-resident protein folding
machinery has overall yielded mixed results. Our
basic understanding of protein folding in the ER is
still incomplete. Addressing these open questions
should underpin engineering approaches to improve
the performance of chaperone systems. A more
detailed understanding of chaperone function and
regulation should inform future work to improve
chaperone systems. Co-expression of different hold-
ases or targeting of heterologous or cytosolic
holdases to the ER may yield more consistent
improvements for different heterologous proteins.
The function of overexpressed chaperones may not be
the same as at their normal physiological concentra-
tions, because of the lack of a corresponding increase
in co-chaperones and co-factors. To improve foldase
Biotechnol Lett (2008) 30:187–196 193
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function, concomitant elevation of BiP, its co-chap-
erones, and ATP levels should be attempted.
Engineering of the UPR suggests that mimicking
an UPR by expression of its activated signaling
molecules does not consistently improve productiv-
ities. Dissection of UPR signaling activities may be
necessary to improve heterologous protein secretion.
To place engineering of the UPR on an informed
basis, we need to understand the UPR in more detail.
It is still not clear what the most upstream events in
activation of the UPR are, how UPR signaling
integrates into cellular signaling, and how the UPR
decides between a prosurvival and an apoptotic
response to ER stress. Cell engineering also needs
to address the potential problem that increased
oxidative protein folding may be inherently toxic to
cells, because of elevated cellular ROS levels.
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